No individual company has been able to capture the market. Globalisation of the pharmaceutical industry has led to many challenges. There are a number of unique features. The needs and requirements vary greatly in different parts of the world. In many underdeveloped countries antimalarials are the priority while in western countries medication such as antihypertensives are in demand.
Longevity increases the demand for diseases associated with old age.
Increasing prosperity leads to greater use of pharmaceuticals. Elan are developing new agents for MS, Crohn s, Alzheimers Clinical outcome is the most important issue for the pharmaceutical industry and doctor Mr. Geaney stated that as an accountant I am more happy analysing the past than predicting the future . He described how groups of experts from differing backgrounds are employed to advise what areas of the industry should be developed. Gene mapping and biotechnology are examples of exciting but costly areas of research and development. Clinical trials can now be conducted globally.